Compile Data Set for Download or QSAR
Report error Found 38 Enz. Inhib. hit(s) with all data for entry = 50005807
TargetCoagulation factor X(Human)
Daiichi Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM17283((2S)-3-(7-carbamimidoylnaphthalen-2-yl)-2-(4-{[(3S...)
Affinity DataIC50: 70nMAssay Description:In vitro evaluation for the concentration needed for inhibiting factor Xa by 50%More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Daiichi Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50041220(1,2-bis(5-amidinobenzofuran-2-yl)ethane | 2-(2-{5-...)
Affinity DataIC50: 100nMAssay Description:In vitro evaluation for the concentration needed for inhibiting factor Xa by 50%More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Daiichi Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50041218(CHEMBL19660 | 3-(7-Carbamimidoyl-naphthalen-2-yl)-...)
Affinity DataIC50: 160nMAssay Description:In vitro evaluation for the concentration needed for inhibiting factor Xa by 50%More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Daiichi Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50041221(3-(7-Carbamimidoyl-naphthalen-2-yl)-2-[4-((S)-pyrr...)
Affinity DataIC50: 200nMAssay Description:In vitro evaluation for the concentration needed for inhibiting factor Xa by 50%More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Daiichi Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50041231(3-(7-Carbamimidoyl-naphthalen-2-yl)-2-[4-((S)-pyrr...)
Affinity DataIC50: 310nMAssay Description:In vitro evaluation for the concentration needed for inhibiting factor Xa by 50%More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Daiichi Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50041219(3-(6-Carbamimidoyl-naphthalen-2-yl)-2-{4-[(S)-1-(1...)
Affinity DataIC50: 360nMAssay Description:In vitro evaluation for the concentration needed for inhibiting factor Xa by 50%More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Daiichi Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50041224((R)-3-(7-Carbamimidoyl-naphthalen-2-yl)-2-{4-[(S)-...)
Affinity DataIC50: 500nMAssay Description:In vitro evaluation for the concentration needed for inhibiting factor Xa by 50%More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Daiichi Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50041217(3-(5-Carbamimidoyl-benzofuran-2-yl)-2-{4-[(S)-1-(1...)
Affinity DataIC50: 500nMAssay Description:In vitro evaluation for the concentration needed for inhibiting factor Xa by 50%More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Daiichi Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50041216(CHEMBL19368 | CHEMBL536721 | 2-(2-{4-[(S)-1-(1-Imi...)
Affinity DataIC50: 640nMAssay Description:In vitro evaluation for the concentration needed for inhibiting factor Xa by 50%More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Daiichi Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50041223(3-(6-Carbamimidoyl-benzofuran-2-yl)-2-{4-[(S)-1-(1...)
Affinity DataIC50: 840nMAssay Description:In vitro evaluation for the concentration needed for inhibiting factor Xa by 50%More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Daiichi Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50041215(2-{2-[4-((S)-Pyrrolidin-3-yloxy)-phenyl]-ethyl}-be...)
Affinity DataIC50: 940nMAssay Description:In vitro evaluation for the concentration needed for inhibiting factor Xa by 50%More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Daiichi Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50041222(3-(5-Carbamimidoyl-benzofuran-2-yl)-2-[4-((S)-pyrr...)
Affinity DataIC50: 1.00E+3nMAssay Description:In vitro evaluation for the concentration needed for inhibiting factor Xa by 50%More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Daiichi Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50041226(3-(5-Carbamimidoyl-benzofuran-2-yl)-2-[4-((S)-pyrr...)
Affinity DataIC50: 1.50E+3nMAssay Description:In vitro evaluation for the concentration needed for inhibiting factor Xa by 50%More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Daiichi Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50041227(3-(6-Carbamimidoyl-benzofuran-2-yl)-2-[4-((S)-pyrr...)
Affinity DataIC50: 1.70E+3nMAssay Description:In vitro evaluation for the concentration needed for inhibiting factor Xa by 50%More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Daiichi Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50041214(3-(6-Carbamimidoyl-benzofuran-2-yl)-2-[4-((S)-pyrr...)
Affinity DataIC50: 1.70E+3nMAssay Description:In vitro evaluation for the concentration needed for inhibiting factor Xa by 50%More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetProthrombin(Human)
Daiichi Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50041216(CHEMBL19368 | CHEMBL536721 | 2-(2-{4-[(S)-1-(1-Imi...)
Affinity DataIC50: 4.00E+3nMAssay Description:In vitro evaluation for the concentration needed for inhibiting thrombin by 50%More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Daiichi Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50041225(3-(6-Carbamimidoyl-naphthalen-2-yl)-2-[4-((S)-pyrr...)
Affinity DataIC50: 4.10E+3nMAssay Description:In vitro evaluation for the concentration needed for inhibiting factor Xa by 50%More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Daiichi Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50041228(3-(6-Carbamimidoyl-naphthalen-2-yl)-2-[4-((S)-pyrr...)
Affinity DataIC50: 4.20E+3nMAssay Description:In vitro evaluation for the concentration needed for inhibiting factor Xa by 50%More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetProthrombin(Human)
Daiichi Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50041220(1,2-bis(5-amidinobenzofuran-2-yl)ethane | 2-(2-{5-...)
Affinity DataIC50: 5.00E+3nMAssay Description:In vitro evaluation for the concentration needed for inhibiting thrombin by 50%More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetProthrombin(Human)
Daiichi Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50041229(2-(5-Carbamimidoyl-benzofuran-2-yl)-3-[4-((S)-pyrr...)
Affinity DataIC50: 9.00E+3nMAssay Description:In vitro evaluation for the concentration needed for inhibiting thrombin by 50%More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetProthrombin(Human)
Daiichi Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50041217(3-(5-Carbamimidoyl-benzofuran-2-yl)-2-{4-[(S)-1-(1...)
Affinity DataIC50: 1.50E+4nMAssay Description:In vitro evaluation for the concentration needed for inhibiting thrombin by 50%More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetProthrombin(Human)
Daiichi Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50041230(2-(5-Carbamimidoyl-benzofuran-2-yl)-3-[4-((S)-pyrr...)
Affinity DataIC50: 2.00E+4nMAssay Description:In vitro evaluation for the concentration needed for inhibiting thrombin by 50%More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetProthrombin(Human)
Daiichi Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50041222(3-(5-Carbamimidoyl-benzofuran-2-yl)-2-[4-((S)-pyrr...)
Affinity DataIC50: 2.10E+4nMAssay Description:In vitro evaluation for the concentration needed for inhibiting thrombin by 50%More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetProthrombin(Human)
Daiichi Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50041219(3-(6-Carbamimidoyl-naphthalen-2-yl)-2-{4-[(S)-1-(1...)
Affinity DataIC50: 2.20E+4nMAssay Description:In vitro evaluation for the concentration needed for inhibiting thrombin by 50%More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetProthrombin(Human)
Daiichi Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50041214(3-(6-Carbamimidoyl-benzofuran-2-yl)-2-[4-((S)-pyrr...)
Affinity DataIC50: 3.60E+4nMAssay Description:In vitro evaluation for the concentration needed for inhibiting thrombin by 50%More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetProthrombin(Human)
Daiichi Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50041228(3-(6-Carbamimidoyl-naphthalen-2-yl)-2-[4-((S)-pyrr...)
Affinity DataIC50: 3.80E+4nMAssay Description:In vitro evaluation for the concentration needed for inhibiting thrombin by 50%More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Daiichi Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50041229(2-(5-Carbamimidoyl-benzofuran-2-yl)-3-[4-((S)-pyrr...)
Affinity DataIC50: 4.50E+4nMAssay Description:In vitro evaluation for the concentration needed for inhibiting factor Xa by 50%More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Daiichi Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50041230(2-(5-Carbamimidoyl-benzofuran-2-yl)-3-[4-((S)-pyrr...)
Affinity DataIC50: 5.20E+4nMAssay Description:In vitro evaluation for the concentration needed for inhibiting factor Xa by 50%More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetProthrombin(Human)
Daiichi Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50041225(3-(6-Carbamimidoyl-naphthalen-2-yl)-2-[4-((S)-pyrr...)
Affinity DataIC50: 1.00E+5nMAssay Description:In vitro evaluation for the concentration needed for inhibiting thrombin by 50%More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetProthrombin(Human)
Daiichi Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50041215(2-{2-[4-((S)-Pyrrolidin-3-yloxy)-phenyl]-ethyl}-be...)
Affinity DataIC50: 1.00E+5nMAssay Description:In vitro evaluation for the concentration needed for inhibiting thrombin by 50%More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetProthrombin(Human)
Daiichi Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50041226(3-(5-Carbamimidoyl-benzofuran-2-yl)-2-[4-((S)-pyrr...)
Affinity DataIC50: 2.30E+5nMAssay Description:In vitro evaluation for the concentration needed for inhibiting thrombin by 50%More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetProthrombin(Human)
Daiichi Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50041223(3-(6-Carbamimidoyl-benzofuran-2-yl)-2-{4-[(S)-1-(1...)
Affinity DataIC50: 4.00E+5nMAssay Description:In vitro evaluation for the concentration needed for inhibiting thrombin by 50%More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetProthrombin(Human)
Daiichi Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50041231(3-(7-Carbamimidoyl-naphthalen-2-yl)-2-[4-((S)-pyrr...)
Affinity DataIC50: 6.00E+5nMAssay Description:In vitro evaluation for the concentration needed for inhibiting thrombin by 50%More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetProthrombin(Human)
Daiichi Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM17283((2S)-3-(7-carbamimidoylnaphthalen-2-yl)-2-(4-{[(3S...)
Affinity DataIC50: 2.00E+6nMAssay Description:In vitro evaluation for the concentration needed for inhibiting thrombin by 50%More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetProthrombin(Human)
Daiichi Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50041221(3-(7-Carbamimidoyl-naphthalen-2-yl)-2-[4-((S)-pyrr...)
Affinity DataIC50: 1.60E+6nMAssay Description:In vitro evaluation for the concentration needed for inhibiting thrombin by 50%More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetProthrombin(Human)
Daiichi Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50041224((R)-3-(7-Carbamimidoyl-naphthalen-2-yl)-2-{4-[(S)-...)
Affinity DataIC50: 1.00E+6nMAssay Description:In vitro evaluation for the concentration needed for inhibiting thrombin by 50%More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetProthrombin(Human)
Daiichi Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50041218(CHEMBL19660 | 3-(7-Carbamimidoyl-naphthalen-2-yl)-...)
Affinity DataIC50: 1.20E+6nMAssay Description:In vitro evaluation for the concentration needed for inhibiting thrombin by 50%More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetProthrombin(Human)
Daiichi Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50041227(3-(6-Carbamimidoyl-benzofuran-2-yl)-2-[4-((S)-pyrr...)
Affinity DataIC50: 1.00E+6nMAssay Description:In vitro evaluation for the concentration needed for inhibiting thrombin by 50%More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed